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Some reports on renal cell tumours (RCTs) have shown evidence
of multicentricity and/or bilaterality, in addition to various genetic
and morphologic changes (Mukamel et al, 1988; Cheng et al,
1991; Henn et al, 1993; Zbar et al, 1994; Kletscher et al, 1995;
Koolen et al, 1998). Although the incidence of multiple sporadic
RCTs in the same kidney was estimated by Schubert (1984) to be
2–4%, prospective analysis of 100 radical tumour nephrectomy
specimens showed 16% incidence (Kletscher et al, 1995).
Tumours of different histology may be combined within one
kidney (Kovács and Hoene, 1987; Delahunt and Eble, 1997).
Many studies have shown various genetical changes in multi-
centric RCTs (Kovács and Hoene, 1987; Kovács et al, 1989; Henn
et al, 1993; Zbar et al, 1994; Koolen et al, 1998); however, these
studies used short-term cell culture, which, because of possible
selection artefacts may not give accurate reflection of the cyto-
genetic characteristics of the RCTs being analysed (Wu et al,
1996). Furthermore, although chromosomal in situ hybridization
(CISH) has been applied in the analyses of RCTs (El-Naggar et al,
1995; Wu et al, 1996; Siebert et al, 1998), few targeted studies
have been performed on tumour nephrectomy specimens
displaying simultaneously separate foci with different cytomor-
phologies.
Conventional renal cell carcinomas (RCCs) reveal in more than
90% of cases loss of heterozygosity on 3p or monosomy 3 as the
primary aberration (Kovács and Frisch, 1989; Meloni et al, 1992;
Van den Berg et al, 1993; Amo-Takyi et al, 1998; Koolen et al,
1998). On the other hand, classical cytogenetics of multicentric
papillary RCTs, whether adenomas or carcinomas, displayed
common primary chromosomal aberrations in different foci,
namely trisomy 17 and tri- or tetrasomy 7 (Kovács et al, 1991;
Henn et al, 1993). These studies therefore associate specific
genetic alterations with defined tumour cytomorphologies, as is
reflected in the classification of RCTs (Störkel et al, 1997).
A common procedure in the cited reports involved the use of
classical cytogenetics, a method which depends on tissue disag-
gregation and cell culturing, and allows statements about neither
tissue morphology nor about relationships between tumours and
their surrounding tissues. Conversely, CISH allows both determi-
nation of genetical changes and histological diagnosis (Neumann,
1987), and in situ verification of chromosomal anomalies by the
histopathologist, whilst obviating the necessity for cell cultures or
DNA extraction. It also permits concurrent assignment of chromo-
some changes to specific cellular or subcellular regions and judge-
ment on their topological distributions (Gutenbach and Schmid,
1990).
In the event that the chromosomal aberrations demonstrated in
the studies above are related specifically to conventional RCCs or
papillary RCTs (adenomas and carcinomas), then each tumour
focus in a multicentric disease should show the chromosomal
aberrations associated with the particular cytomorphology of its
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mosomes 3, 7 or 17 could be demonstrated in each tumour focus of
archived, formalin-fixed, paraffin-embedded sections of sporadic
multicentric RCTs (blocks aged 1–6 years), using CISH. This was
to demonstrate and validate the use of the CISH method in deter-
mining specific chromosomal aberrations in RCTs. We further
sought for differences in chromosomal aberrations in relation to
tumour size, stage, grade, intratumoral heterogeneity and also
concordance or discordance of chromosomal changes between
different foci in a specimen.
MATERIALS AND METHODS
Two hundred and thirty-nine nephrectomy cases with sporadic
RCTs were analysed for multicentricity. Thirty-four (14%) of them
contained multiple tumours. Fifteen cases with 34 foci (16 conven-
tional carcinomas, and 18 papillary RCTs (11 carcinomas and
seven adenomas)) were analysed with CISH, using centromere-
specific a-satellite probes for chromosomes 3, 7 or 17. To study
the relationships between tumour size, malignancy, grade, differ-
entiation and chromosomal aberrations, the 15 cases were selected
to include adenomas and carcinomas, large- and small-sized
tumours, high- and low-grade tumours, and cases (nine out of 15)
with both conventional carcinomas and papillary tumours
(adenomas and/or carcinomas) which were spatially separated by
normal renal tissues.
Histological procedure
Sections of the formalin-fixed, paraffin-embedded tumour speci-
mens were stained in haematoxylin and eosin, and histological
classification was performed as recommended by Störkel et al
(1997) and Srigley et al (1997). Papillary tumours were considered
adenomas when they were less than 5 mm, and did not fit into
category I (Srigley et al, 1997); and all conventional tumours,
irrespective of size, were classified as carcinomas.
CISH
CISH was performed on paraffin sections of each tumour focus
and surrounding normal renal tissues as described previously
(Amo-Takyi et al, 1998), using the three chromosomes mentioned.
Briefly, the 5- to 6-mm thin paraffin-embedded sections were
mounted on sialinized slides and incubated at 60°C for 2 h. The
sections were dewaxed in two changes of xylene, followed by two
treatments in 100% ethanol immediately after the incubation.
Proteinase K (Sigma, St Louis, MO, USA; 20 mg ml–1 in phos-
phate-buffered saline (PBS)) digestion was performed in a humid-
ified chamber at 37°C for 2 min. The sections were rinsed imme-
diately in PBS and incubated with RNAase (Boehringer
Mannheim, Germany; 40 mg ml–1 in standard saline citrate) in a
humidified chamber at 37°C for 1 h, post-fixed in 4% (w/v)
paraformaldehyde in PBS for 3 min, rinsed in PBS and dehydrated
in a graded ethanol series (50%, 70%, 90%, 100%) each for 3 min
at room temperature and air-dried for 10 min. Ten microlitres of
the DNA probes (digoxigenin-labelled a-satellite DNA probes for
chromosomes 3, 7 or 17, concentration 1 mg 100 ml–1, Oncor,
Gaithersburg, MD, USA) per slide were pipetted into Eppendorf
tubes and denatured in a water bath at 95°C for 5 min and immedi-
ately transferred onto ice for 2 min. The sections were also dena-
tured separately in distilled autoclaved water at 95°C for 5 min and
immediately transferred onto ice for 2 min. The sections were then
allowed to air dry. Previously prepared hybridization mix (30 ml
of 2 ´ hybridization buffer; Gibco-BRL, Life Technologies,
Eggenstein, Germany and 40 ml of 10% (w/v) dextran sulphate)
was added to the denatured DNA probes and applied onto each
section, covered with coverslips, denatured for 10 min at 90°C,
placed on ice for 2 min and incubated overnight in a humidified
chamber at 37°C. Stringency washings with 60% (v/v) formamide
in 2 ´ SET27 (50 mM Tris–HCl, 300 mM sodium chloride (NaCl),
2m M EDTA and 0.5% Triton X-100) at 37°C were performed at
the end of the incubation. The sections were subsequently blocked
with a solution containing bovine serum albumin, followed by
application of alkaline phosphatase-labelled digoxigenin anti-
body (Boehringer Mannheim, Germany), and incubated at 37°C in
a humidified chamber for 45 min. The hybrids formed were
detected with nitroblue tetrazolium and 4-bromo-5-chloro-3-
indolylphosphate (Gibco-BRL, Life Technologies, Eggenstein,
Germany) for 18 h, counterstained in 1% methyl green in aqueous
solution, and mounted permanently in eukitt. Hybridization
signals were counted in 450 cell nuclei (running mean) for each
chromosome. Internal controls were performed on normal renal
tubular epithelial cells.
Statistical analysis
The Wilcoxon rank sum test was used to examine the frequency
distribution of hybridization signals. Comparisons of individual
cases were performed with the Kruskal–Wallis test. Wilcoxon
2-Sample test was used to analyse the combined number of
hybridization signals (1, 2, 3 etc.). Simple statistics and Pearson’s
correlation coefficients were also applied to establish the differ-
ences in chromosomal aberrations between small (≤ 1 cm) and
large (> 1–15 cm) tumours, and between conventional carcinomas
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Table 1 P-values after CISH for chromosomes 3, 7 or 17: comparison of signal distributions between the tumours and their surrounding normal kidney tissues
P-value
Signals/cell Chromosome 3 Chromosome 7 Chromosome 17
NK vs CC NK vs PT NK vs CC NK vs PT NK vs CC NK vs PT
1 0.0042* 0.2696 0.5832 0.0211 0.7227 0.0182
2 0.0001 0.1834 0.0009 0.0012 0.0011 0.0020
3 – 0.0006a 0.0011a 0.0020a 0.0002 0.0001a
4 – 0.0023a 0.0042a 0.0011a 0.0022 0.0041a
a Relevant P-values. Significant value: P ≤ 0.05; –: not performed; NK = normal kidney tissue; CC = conventional RCCs; PT = papillary RCTs.and papillary RCTs as well. Significance was set at P ≤ 0.05.
Relevant P-values are marked with asterisks (*). Other irrelevant
but significant values are caused by a shift in the equilibrium as
soon as defined hybridization signals, i.e. 1, 2, 3 signals etc.
outweigh. The P-values are summarized in Tables 1 and 2.
Interpretation of results
Chromosomal changes in the normal renal tubular epithelial cells
served as reference in defining the aberrations. Statistical evalua-
tion of earlier work in our laboratory (unpublished data) revealed
that 40% ± 5% of the nuclei in normal renal tubular epithelial
tissues of 5- to 6-mm thickness display one hybridization signal
after CISH. This stems from artefacts caused by truncation of
some cell nuclei during tissue sectioning. Accordingly, a display of
two hybridization signals of a diploid chromosome in at least 55%
of the cell nuclei in a normal tissue of 5- to 6-mm thickness, even
in the face of maximal truncations (45%), is viewed as disomic
(normal). Hence, an increase of the upper value (45%) by at least
2D (D = +5%) indicated a tendency to a monosomy of the chro-
mosome under investigation. Therefore tissues with 45% + 3D%
or more one-hybridization signals of a particular chromosome
were diagnosed as having acquired monosomies of that chromo-
some. Conversely, irrespective of the chromosome examined, a
maximum of 5% (D) nuclei in 5- to 6-mm thick sections of normal
tissues show three signals per nucleus after CISH. A trisomy was
hence diagnosed only when D increased by at least twice (i.e.
trisomy: ³ 15% three hybridization signals). Cell subpopulations
were considered when more than 5%, but less than 15% of the
tumour cell nuclei revealed three or more copies of a chromosome.
RESULTS
Histomorphology
Table 3 gives detailed demographic information, including tumour
differentiation and sizes. Thirty-four cases (14%) revealed multi-
centric RCTs. Each multicentric case contained at least two
tumours. Most of the solitary cases were carcinomas, of which ten
demonstrated extensive metastases at the time of clinical presenta-
tion. The smallest solitary RCT (a 4 mm adenoma) was detected
incidentally in the course of an operation for urothelial carcinoma.
Chromosomal aberrations determined by CISH
Normal renal tubular epithelial and surrounding stromal cells
displayed mostly two hybridization signals, or sometimes one
Cytogenetics of paraffinized multicentric renal cell tumours 1409
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Table 2 P-values after CISH for chromosomes 3, 7 or 17: comparison of
signal distributions between conventional RCCs and papillary RCTs
P-value
Signals/cell Chromosome 3 Chromosome 7 Chromosome 17
1 0.0002a 0.0114 0.0315
2 0.0010 0.3955 0.5508
3 0.1809 0.1158 0.0133a
4 0.8482 0.0519 0.7974
aRelevant P-values. Significant value: P ≤ 0.05.
Table 3 Demographic details of the patients, including tumour sizes and
differentiation.
Solitary RCTs Multicentric RCTs
No. of cases 205 34 (14%)
Male:female ratio 1.4:1 2:1
Male average age (years) 59.4 60.1
Female average age (years) 62.5 67
Tumour sizes (range) 4 mm–15 cm < 2 mm–15 cm
Differentiation
Conventional RCC 83% 47%
Papillary RCTs 5% 53%
Chromophobe RCTs 2% –
Oncocytoma 10% –
Table 4 Relationship of chromosomal findings with histological grade and stage in 16 conventional RCCs
Case Cell type Tumour Histological Tumour Chromosomal
number size (cm) grade stage findings
1 a:clear 15 3 3b Monosomy 3
b:clear 0.5 2 – Disomy 3
2 a:clear 3 3 3a Disomy 3
4 a:clear 8.5 2 2 Disomy 3
b:clear 0.8 3 – Monosomy 3
c:clear 0.8 1 – Disomy 3
5 a:clear 7 3 3a Disomy 3
b:clear 6 3 – Disomy 3
6 a:clear 4 2 2 Disomy 3
7 a:clear 2 2 2 Disomy 3
8 a:clear 3 2 2 Disomy 3
9 a:clear 8 2 3b Disomy 3
b:clear 0.4 1 – Disomy 3
12 a:clear 13 2 2 Monosomy 3
13 a:clear 2.7 2 2 Disomy 3
14 a:clear 4.5 1 2 Disomy 3
a, b and c denote different tumour foci in the same kidney specimen; –, not done. Tumour staging was only performed for the
biggest tumour in each specimen. Relevant findings are set in bold face.hybridization signal (truncated nuclei), irrespective of the chromo-
some examined (Figure 1A).
Three conventional RCCs sized 8 mm, 13 cm and 15 cm respec-
tively, exhibited monosomy 3 (Figure 1B, Table 4), and 13
conventional RCCs were disomic. Three conventional RCCs had
trisomy 7 and cell subpopulations with four copies of chromosome
7. The remaining 13 conventional RCCs had disomy 7 (Figure
1C); however, they also showed various cell subpopulations with
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Figure 1 (A) Normal renal tubular epithelial and surrounding stromal cells after CISH for chromosome 3. Like all subsequent hybridizations, it was
counterstained in 1% methyl green. The cells display either one (arrowheads) or two hybridization signals (arrows). Chromosomes 7 and 17 also showed similar
results. (B) A representative section of conventional RCC after CISH for chromosome 3, revealing mostly only one copy of the chromosome per nucleus
(insert). (C) Conventional RCC after CISH for chromosome 7. As shown in the insert, most cells show two, and a few three hybridization signals. (D)
Conventional RCC after CISH for chromosome 17, displaying mostly two copies (insert). (E) Overview of papillary RCC after CISH for chromosome 17. Insert
shows magnified tumour nuclei with the characteristic three copies per nucleus. (F) Overview of papillary RCC after CISH for chromosome 7. Insert displays
enlarged tumour nuclei with the characteristic three or four copies of chromosome 7 per nucleus. three (5.62–12.27%) and four (0–5.09%) copies of chromosome 7,
respectively, as shown in the insert of Figure 1C. All 16 conven-
tional RCCs were disomic for chromosome 17 (Figure 1D), never-
theless, there were cell subpopulations with three (6.94–13.77%)
and four (0–4.57%) hybridization signals of chromosome 17
respectively.
Fourteen papillary RCTs (both adenomas and carcinomas)
revealed trisomy 17 (Figure 1E). Three further small papillary
RCTs (≤ 1 cm) displayed 14.49%, 14.68% and 14.86% cells,
respectively, with three copies of chromosome 17. Ten papillary
RCTs had tri- or tetrasomy 7 (Figure 1F). Even small papillary
adenomas such as in Figure 1G-I (4 mm) revealed the character-
istic trisomy 17 (Figure 1G-II). The results are summarized in
Figures 2–5.
DISCUSSION
The 14% sporadic multicentric RCTs observed in this study, and
the 16% reported by Kletscher et al (1995) indicate a higher
frequency of sporadic multicentric RCTs than the 2–4% assumed
by Schubert (1984). Neither the tumour differentiation nor the
chromosomal aberrations detected with CISH were related to
patient age or gender. The differentiation of the solitary tumours
were similar to those reported by others (Kovács, 1990; Linehan
et al, 1995); however, the multicentric disease showed 47%
Cytogenetics of paraffinized multicentric renal cell tumours 1411
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Figure 1 (continued) (G-I) A small papillary renal adenoma; (G-II) A section
of the adenoma after CISH for chromosome 17, revealing the characteristic
three copies of the chromosome in some nuclei (arrows; insert). (H)
Conventional RCC after CISH for chromosome 17 showing intratumoral
heterogeneity. Note the focal cluster of cells with three copies (arrowheads);
in contrast, the surrounding cells predominantly have two copies of the
chromosome
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Figure 2 Mean frequency distribution of signals after CISH. Roughly 40%
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Figure 3 Graphical presentation of multicentric papillary RCTs of different
sizes, after CISH for chromosome 7. F1, F2 and F3 denote separate tumour
foci in a specimen. Apart from three cases (**), there is some reduction of the
copy numbers with tumour growthconventional RCCs (against 83% conventional RCCs in the cases
with solitary RCTs) and 53% papillary RCTs (against 5% in the
solitary RCTs). This demonstrates that papillary RCTs are liable to
multicentricity, a fact which is of clinical importance.
Chromosomal aberrations: multicentric conventional
RCCs
Only three of the 16 conventional RCCs, sized 8 mm (G3), 13 cm
(pT2, G2) and 15 cm (pT3b, G3), respectively, and all either high-
grade or in advanced disease stages, exhibited monosomy 3.
Hence, although monosomy 3 is characteristic of conventional
RCCs (Kovács and Frisch, 1989; Amo-Takyi et al, 1998) heedless
of size, its cytogenetical diagnostic value is limited, and can only
be found in advanced- and/or high-grade tumours. Three conven-
tional RCCs had trisomy 7 and disomy 17 and the rest were
disomic for both chromosomes 7 and 17; however, the latter also
showed various cell subpopulations with three or four copies of
either chromosomes. Furthermore, comparison of the different
foci in the same specimen was uninformative in the conventional
RCCs.
Intratumoral heterogeneity was also clearly evident in all the
tumours. There were clusters of compact, tubular or singular cell
arrangements with higher copy numbers of all three tested
chromosomes compared with the surrounding tumour cells
(Figure 1H). This observation which is duly documented as
subpopulations in this report, vividly demonstrates the hetero-
geneity of cell populations in a piece of tumour tissue. This brings
to light that the end diagnosis whether mono-, di-, or trisomy etc.
irrespective of the chromosome examined, is in fact, a subsuma-
tion of the actual chromosomal events taking place in a piece of
tumour tissue. Consequently, intratumoral heterogeneity can not
be demonstrated in studies which use classical cytogenetics or
DNA cytometric analysis of tissues to detect aberrations or ploidy
statuses due to the obligatory tissue disaggregation associated with
both methods. Evidently, tissue disaggregation not only incapaci-
tates histomorphological assessment, but also can lead to inaccu-
rate genetic results since some heterogenous cell subpopulations
may be missed at the time of tissue sampling.
No significant differences were observed in chromosomal aber-
rations between small and big conventional RCCs. Trisomy 7, a
consistent abnormality in RCTs (Hogemann et al, 1994), and like-
wise increased copies of chromosome 17 appear to be expressions
of general chromosomal instability in conventional RCCs in the
course of tumour progress, and do not reflect specific cytogenetic
changes.
It is histologically not possible to differentiate between primary
tumours and their metastases based on tumour sizes alone. Again,
a small tumour is not de facto metastasis of a bigger one, since a
new tumour focus can develop even in the presence of a bigger
one. The resolution of this question in cases 1, 4, 5 and 9 may have
been provided by clonality analysis. Unfortunately, all four cases
occurred in men, and hence, the well-known clonality analysis
based on the pattern of X-chromosome inactivation (Tamura et al,
1998) was inapplicable. Clonality analysis was, nevertheless, not
considered in those cases showing separate foci with different
cytomorphologies, since no relationships could be envisaged.
However, analyses are underway to clarify the clonality of some
multifocal female RCTs, and the findings will be the subject of our
next paper.
Chromosomal aberrations: multicentric papillary RCTs
Fourteen of 18 papillary RCTs, both adenomas and carcinomas,
revealed trisomy 17, without limitation to size or grade. Three
further papillary RCTs had high numbers of cells with three
hybridization signals: 14.49%, 14.68% and 14.86%, respectively,
and were assumed to be incipient for trisomy 17 (see Figure 5).
The results generally indicate a tumour type with a cytogenetic
aberration unparalleled to other RCT subtypes. Apparently, all the
three tumours incipient for trisomy 17 and the disomic tumour
(10.14% cells with three copies of chromosome 17), are small
tumours (≤ 1 cm). This presents a unique cytogenetic character of
papillary RCTs, which though not restricted to size, showed an
inclination to increased copy numbers with growing tumour size;
showing a near significant P-value of 0.055. Moreover, the papil-
lary RCTs were more susceptible to developing tri- or tetrasomy 7
compared to conventional RCCs.
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Figure 4 A diagrammatical presentation of chromosomal aberrations in the
16 multicentric conventional RCCs. Monosomy 3 begins at 60%
Figure 5 A pictorial presentation of chromosomal aberrations in the
18 multicentric papillary RCTs. Tumours < 1 cm are considered small.
Trisomy 17 starts from 15%Despite the fact that tri- or tetrasomy 7 were common to papil-
lary RCTs in general, the percentage of cells with three or four
copies in the smaller papillary tumours, on average 19.36%, were
comparably higher than those of the bigger papillary RCTs, which
had a mean value of 11.84%. This implies that whereas smaller
papillary RCTs, mostly adenomas, had overt tendencies to
acquiring extra copies of chromosome 7, some copies got lost
with continued tumour growth. This reduction, which was also
observed in one small (2 mm) histologically grade 3 papillary
tumour, probably reflects malignant transformation. Interestingly,
focal areas of the papillary RCTs that showed clear cytoplasms,
also revealed trisomies 17 and 7, meaning that growth pattern in
papillary RCTs as it seems, might play a more dominant role than
can possibly be ascribed to the morphological changes in the
cytoplasm.
Comparison of different papillary RCT foci in the same spec-
imen showed a general tendency of the bigger tumours to acquire
three copies of chromosomes 3 and 17. This was generally
reflected in near-significant P-values of 0.054 for trisomy 3 and
0.055 for trisomy 17 respectively. Moreover, as was observed in
conventional RCCs, there were also heterogenous cell subpopula-
tions in both papillary adenomas and papillary RCCs. Further,
there was generally concordance of the basic chromosomal aberra-
tions in the different foci in each specimen, i.e. the papillary
tumours whether adenomas or carcinomas, revealed trisomy 17,
in addition to di- or trisomy 7.
One small (2 mm) papillary tumour was not only histologically
grade 3, but also showed disomy 7, which appeared in this report
to be associated with malignancy. Consequently, this report does
not support a strict differentiation of papillary adenomas from
papillary RCCs based on whether or not 5 mm has been exceeded.
We believe that both the histological grade and genetical changes
should be considered, or else strict adherence to size alone may
lead, in our opinion, to a false sense of security.
Tissue thickness and truncation artefacts in the nuclei
The use of cell cultures or methods which disaggregate tissues by
more or less maintaining the integrity of the individual cells, e.g.
whole cell suspensions, cause minimal damage to cell membranes
and hence, minimal loss of genetic material from the cell nuclei.
However, such methods incapacitate histomorphological assess-
ment, and therefore analysis of phenomena like intratumoral
heterogeneity.
Nucleic acids in fixed tissue sections, i.e. the target DNAs, have
to be unmasked and made available to the labelled DNA probe to
be examined. The mainstay of this process is proteolytic digestion,
which removes components of the cell nucleus and cytoplasm to
allow probe access (Herrington, 1998). Thicker sections may not
only be difficult to assess histomorphologically, but also may
either need more proteolytic enzyme to make the target accessible
to the probe and therefore increase the danger of overdigestion, or
may be underdigested; in which cases there will be either loss
of genetic material or suboptimal probe penetration. Thinner
sections, on the other hand, may lead to overdigestion, and hence,
destruction of cell and tissue architecture. This, thus, leads to loss
of target DNA and morphological detail. In both these situations,
there will be relative failure of the hybridization reaction as probe
and target DNA are not brought together under optimal conditions
(Herrington, 1998).
We initially performed the CISH, using sections of 3- to 4-mm
thickness, just as in routine histology, for optimal morphologic
assessment. In tissues of 3- to 4-mm thickness, ³ 60% of the cell
nuclei revealed one hybridization signal. Considering, however,
that the average RCT nucleus has a diameter of about 7 mm, we
found that the overrepresentation of one hybridization signal
resulted from truncation artefacts, since with 3- to 4-mm sections
we were only assessing about 40–60% of the nuclear DNA in each
cell. Consequently tissue sections of 5- to 6-mm thickness were
used. This allowed by optimal preservation of morphology and
target accessibility to probe, evaluation of about 70–90% of the
nuclear DNA per cell. In a word, selection of thin sections without
regarding the average nuclear size of the cells in question may
produce a biased high number of truncated cell nuclei, and inaccu-
rate results.
The multicentric RCTs provided a good basis for assessing
the chromosomal alterations in each focus whatever their cyto-
morphologies, in excellently preserved tissue morphology.
Additionally, information pertaining to the tumour and its
surrounding tissue was also obtainable. The method allowed a
distinction of normal kidney tissues from conventional RCCs or
papillary RCTs, and conventional RCCs from papillary RCTs by
revealing different cytogenetic characters. It enabled assessment
of heterogeneity of the tumours with respect to ploidy of indi-
vidual cells in a single tumour, and underlined its potential in
retrospective genetical characterization of paraffinized tumour
tissues.
In conclusion, monosomy 3, although not restricted to tumour
size, appears to be limited to high-grade and/or advanced conven-
tional RCCs. Whereas the number of cells with three copies of
chromosome 17 in papillary RCTs seem to increase with tumour
growth, bigger tumours of the same subtype showed lesser
numbers of cells with three copies of chromosome 7, possibly
reflecting malignant transformation. These results, as it appears,
might suggest that specific chromosomal alterations, in particular
monosomy 3 in conventional RCCs and loss of chromosome 7 in
papillary RCTs, since both were associated with histologically
high-grade and/or advanced tumours, might be of value in
predicting disease outcome.
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